Davenport & CO LLC Novartis Ag Transaction History

Davenport & CO LLC

$16.8 Billion
Q3 2024

A detailed history of Davenport & CO LLC transactions in Novartis Ag stock. As of the latest transaction made, Davenport & CO LLC holds 33,778 shares of NVS stock, worth $3.69 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

33,778

Previous 34,493 2.07%

Holding current value

$3.69 Million

Previous $3.67 Million 5.8%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$106.13 - $120.89 $75,882 - $86,436	-715 Reduced 2.07%	33,778 $3.89 Million
Q2 2024 Aug 06, 2024	BUY	$92.57 - $107.37 $13,700 - $15,890	148 Added 0.43%	34,493 $3.67 Million
Q1 2024 May 03, 2024	BUY	$95.27 - $108.47 $208,641 - $237,549	2,190 Added 6.81%	34,345 $3.32 Million
Q4 2023 Jan 23, 2024	SELL	$92.27 - $101.54 $89,778 - $98,798	-973 Reduced 2.94%	32,155 $3.25 Million
Q3 2023 Oct 17, 2023	SELL	$94.73 - $105.13 $386,498 - $428,930	-4,080 Reduced 10.97%	33,128 $3.37 Million
Q2 2023 Jul 20, 2023	SELL	$92.52 - $104.91 $315,215 - $357,428	-3,407 Reduced 8.39%	37,208 $3.75 Million
Q1 2023 Apr 27, 2023	BUY	$80.03 - $92.81 $280,425 - $325,206	3,504 Added 9.44%	40,615 $3.74 Million
Q4 2022 Jan 20, 2023	SELL	$75.55 - $92.52 $46,538 - $56,992	-616 Reduced 1.63%	37,111 $0
Q3 2022 Oct 11, 2022	BUY	$74.61 - $87.26 $378,198 - $442,320	5,069 Added 15.52%	37,727 $2.87 Million
Q2 2022 Jul 18, 2022	SELL	$80.52 - $93.75 $64,013 - $74,531	-795 Reduced 2.38%	32,658 $2.76 Million
Q1 2022 May 02, 2022	BUY	$80.11 - $90.62 $34,687 - $39,238	433 Added 1.31%	33,453 $2.94 Million
Q4 2021 Feb 10, 2022	SELL	$79.7 - $88.13 $186,896 - $206,664	-2,345 Reduced 6.63%	33,020 $2.89 Million
Q3 2021 Oct 14, 2021	BUY	$81.78 - $95.14 $1.66 Million - $1.93 Million	20,289 Added 134.58%	35,365 $2.89 Million
Q2 2021 Jul 28, 2021	BUY	$85.24 - $94.15 $50,376 - $55,642	591 Added 4.08%	15,076 $1.38 Million
Q1 2021 Apr 28, 2021	BUY	$83.5 - $98.47 $339,678 - $400,575	4,068 Added 39.05%	14,485 $1.24 Million
Q4 2020 Jan 13, 2021	BUY	$78.07 - $94.43 $45,827 - $55,430	587 Added 5.97%	10,417 $984,000
Q3 2020 Oct 15, 2020	SELL	$82.14 - $91.0 $8,706 - $9,646	-106 Reduced 1.07%	9,830 $855,000
Q2 2020 Jul 28, 2020	SELL	$80.93 - $91.1 $16,186 - $18,220	-200 Reduced 1.97%	9,936 $868,000
Q1 2020 May 05, 2020	BUY	$70.67 - $99.01 $24,734 - $34,653	350 Added 3.58%	10,136 $836,000
Q4 2019 Jan 22, 2020	BUY	$84.35 - $95.37 $40,234 - $45,491	477 Added 5.12%	9,786 $927,000
Q3 2019 Oct 16, 2019	SELL	$85.54 - $94.26 $427 - $471	-5 Reduced 0.05%	9,309 $850,000
Q2 2019 Jul 10, 2019	SELL	$75.4 - $92.8 $36,342 - $44,729	-482 Reduced 4.92%	9,314 $850,000
Q1 2019 Apr 17, 2019	SELL	$75.32 - $86.15 $6,929 - $7,925	-92 Reduced 0.93%	9,796 $942,000
Q4 2018 Jan 28, 2019	BUY	$73.66 - $82.02 $64,010 - $71,275	869 Added 9.64%	9,888 $849,000
Q3 2018 Oct 11, 2018	SELL	$66.94 - $77.43 $159,250 - $184,205	-2,379 Reduced 20.87%	9,019 $777,000
Q2 2018 Jul 09, 2018	SELL	$64.91 - $73.36 $11,164 - $12,617	-172 Reduced 1.49%	11,398 $861,000
Q1 2018 Apr 04, 2018	SELL	$70.39 - $84.15 $42,585 - $50,910	-605 Reduced 4.97%	11,570 $935 Million
Q4 2017 Jan 17, 2018	BUY	$72.33 - $77.64 $380,817 - $408,774	5,265 Added 76.19%	12,175 $1.02 Billion
Q3 2017 Oct 12, 2017	BUY	$74.14 - $77.27 $512,307 - $533,935	6,910	6,910 $593 Million

Others Institutions Holding NVS

# of Institutions

1,433

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.55M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $235B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account